The National Joint Registry (NJR) of Wales holds no intention of putting Johnson & Johnson (J&J) in a bad light, medical researchers say. As a matter of fact, DePuy Orthopeadics, a unit of J&J, ASR Hip Systems was just among the brand of prosthesis that they were monitoring in terms in number of high failure rates to protect the welfare of the patients. Unfortunately, DePuy has the most number of design failures compared with other hip implants, which prompted NJR to request the removal of the product from the market.
The removal was supported by organization of hip surgeons across the United Kingdom (UK) by aggressively campaigning among surgeons to stop using the hip implants which has caused trouble not only a couple of hundreds of patients but a thousand. As a matter of fact, after it triggered the global recall initiated by DePuy in 2010, it has collected 93,000 hip implants since then. Still it has not stopped the recipients from filing a compensatory damages lawsuit which has already reached up to 10,000 complaints.
Questions where brought on how did NJR come up with a report which NJR simply answered back through their website that their role was to simply identify failing medical devices. Their aim was to identify any brand of artificial devices that shows high failure rate and to do this; they ask permission from the patients who got the implants to allow them to monitor their progress. The monitoring does not limit only with the hip implants but as well as with knee or ankle joint procedure.
The data gathering function of NJR includes the procedure type and the brand of the artificial devices which is recorded for initial implant procedures and for any revisions of the device. In 2010, 76,759 hip replacement procedures were recorded on the NJR and about 94 percent of these were with the patient’s consent.
The DePuy ASR Hip System, after being approved by the United States Food and Drug Administration (FDA), was distributed in the market in 2003. It was in April 2010 when the report submitted to the NJR Implant Performance Group raised concerns about the performance of the ASR which resulted in the Medicines and Healthcare Products Regulatory Agency (MHRA) being notified which triggered them to investigate into the ASR by DePuy. By September of 2010 they issued a device alert which DePuy issued a worldwide recall of ASR device. To know more about issues related to hip replacement lawsuit check hipreplacementlawsuitcenter.com.
Men and women, whose symptoms of hip osteoarthritis may have failed to respond to conventional treatment, may have hip replacement surgery as their only recourse. However, instead of providing relief, some hip devices have been reported to fail earlier than expected, causing injuries to a large number of recipients.
This article is Copyright free.
Save Tax by Setting Up A Trust